1. Markers for HIV-disease progression in untreated patients and patients receiving AZT: Evaluation of viral activity, AZT resistance, serum cholesterol, β2-microglobulin, CD4+ cell counts, and HIV antigen

   • H. Rübsamen-Waigmann
   • B. Schröder
   • U. Dietrich

   OriginalPaper Pages: S77 - S82

2. Neutralizing antibodies and antigens in AIDS

   • S. G. Norley
   • R. Kurth

   OriginalPaper Pages: S83 - S88

3. Serological markers as prognostic criteria for the course of HIV infection

   • A. Kleinschmidt
   • A. Matuschke
   • R. Hehlmann

   OriginalPaper Pages: S89 - S92

4. Tumor necrosis factor and interferon as prognostic markers in human immunodeficiency virus (HIV) infection

   • G. Hess
   • S. Rossol
   • K. -H. Meyer zum Büschenfelde

   OriginalPaper Pages: S93 - S97

5. Neopterin and β2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection

   • D. Fuchs
   • A. Krämer
   • H. Wachter

   OriginalPaper Pages: S98 - S102

6. Lymphocyte subsets as surrogate markers in antiretroviral therapy

   • J. R. Bogner
   • F. -D. Goebel

   OriginalPaper Pages: S103 - S108